Form 4: AtriCure's Chief Technical Officer, Salvatore Privitera, Increases Stake in Company
SEC Form 4
Salvatore Privitera, Chief Technical Officer of AtriCure, Inc., recently purchased 5,000 shares of the company's common stock.
Summary
- On May 30, 2024, Salvatore Privitera, the Chief Technical Officer of AtriCure, Inc., acquired 5,000 shares of common stock.
- The purchase price was $22.25 per share.
- Following the transaction, Privitera directly owns 103,290 shares of AtriCure's common stock.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. An insider purchase generally indicates confidence, but the scale of the purchase is not large enough to be overwhelmingly positive.
Positives
- The purchase of shares by a company executive can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider transactions are closely monitored by investors as they can provide insights into a company's performance and future expectations. Purchases by executives are often viewed positively.
Stakeholder Impact
- The purchase could have a slightly positive impact on shareholders, signaling confidence from a company executive.
Key Dates
| Date | Description |
|---|---|
| 05/30/2024 | Date of the transaction: Salvatore Privitera purchased 5,000 shares of AtriCure common stock. |
| 05/31/2024 | Date of signature on the SEC Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.